reported a nearly 35‐meter improvement in 6MWD and a 2.5‐fold increase in the odds of WHO class improvement, though the NT‐proBNP change narrowly missed significance [ 7 , 8 , 20 , 21 , 22 ].
← all excerpts
Sotatercept in Pulmonary Langerhans Cell Histiocytosis-Associated Pulmonary Hypertension: A Case Series and Systematic Review.
1
—
—